Cancer clinical trials: questions to ask before taking part

An invitation to discuss a cancer clinical trial is an invitation to understand a particular protocol. It does not mean participation has been approved or that an experimental treatment will necessarily outperform standard care. Prepare questions about both the medical implications and the demands on everyday life.

Establish the purpose and current status

Request the study’s full name, registration number, participating hospital and research-team contact. Ask what question the trial addresses and why it is being considered for your diagnosis. Confirm whether that specific hospital is currently recruiting and whether further assessment is needed before eligibility can be determined.

The NCI information about trial participation explains that a study treatment may not be better than standard treatment and may carry additional risks. Ask for a comparison with the actual alternative outside the trial. “Access to innovation” cannot replace a discussion of possible benefit, uncertainty and known adverse effects.

Understand the medical commitments

Find out which interventions are required and distinguish research procedures from routine monitoring. If the trial has different groups, ask how participants are allocated and what each group receives. Do not assume every participant will receive the same experimental medicine.

At an oncology consultation, provide complete records of previous treatment and investigations. Ask your current doctor how trial consideration fits with the existing care plan and its timing. Participation decisions and changes to treatment need medical discussion; waiting for a research centre’s response does not itself change current instructions.

Translate the protocol into a calendar and budget

Request an outline of mandatory visits, possible hospital stays, expected time near the centre and follow-up after participation ends. Ask which tests can be performed near home and who reviews the results. For a trial abroad, discuss document language, interpreter arrangements and clinical contact between appointments.

Obtain a written explanation of responsibility for the study treatment, routine care, investigations, transport and accommodation. Provision of a study medicine without charge does not remove every other expense. Ask how costs and care are handled if complications occur or participation ends. Funding arrangements from one trial should not be assumed to apply to another.

Make room for informed discussion

Request participant information and consent documents in a language you understand, together with a contact for further questions. Ask how much time is available to decide and who can explain difficult points. Understand privacy arrangements, the process for leaving the study and subsequent care options; these are among the issues raised by NCI.

Before organising medical travel, confirm the status of your case directly with the research team. A screening appointment and enrolment are different stages. Keep the responsible clinician’s details and follow-up arrangements. This guide helps evaluate a proposal; it does not establish that a trial is available or that you meet its eligibility requirements.